Series D - Palvella Therapeutics

Series D - Palvella Therapeutics

Investment Firm

Overview

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Announced Date

Jan 05, 2023

Funding Type

Series D

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

3

Investor Name
Participant InvestorBiotechnology Value Fund
Participant InvestorNolan Capital
Participant InvestorBioAdvance

Round Details and Background

Palvella Therapeutics raised $37700000 on 2023-01-05 in Series D

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 28, 2020
Series C - Palvella Therapeutics
9-45.0M
Dec 30, 2022
Venture Round - Palvella Therapeutics
-9.7M
Jan 05, 2023
Series D - Palvella Therapeutics
7-37.7M
Aug 14, 2017
Venture Round - Palvella Therapeutics
2-undefined

Recent Activity

There is no recent news or activity for this profile.